Pfizer Inc.
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
Published in Medical Device Law Weekly, January 10th, 2010
Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD). SPIRIVA HandiHaler is already FDA-approved as a once-daily maintenance treatment for breathing problems associated with COPD, which includes chronic bronchitis, emphysema, or both.
Reducing exacerbations is a key goal of COPD disease management, according to treatment guidelines. In the clinical trials that served as the basis for this approval, COPD exacerbations were defined...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- AdMeTech Foundation
Congress Approves Defense Spending Bill Containing $1.6 Million for Pioneering Research to Improve Prostate Cancer Imaging - Alliance for Digital Equality
The Alliance for Digital Equality Presents 2010 Digital Empowerment Summit at University of Southern California - American Academy of Dermatology Association
American Academy of Dermatology Association Commends U.S. Senate for Taking Step to Improve Public Health Through Indoor Tanning Tax - Obesity and Diabetes
Researchers from University of Pittsburgh report on findings in obesity and diabetes - 3M
3M Introduces Physician Dictation on BlackBerry and Windows Mobile Smartphones - Abiomed, Inc.
Journal of the American College of Cardiology Publishes European Study Results for Abiomed Impella 2.5 - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
